TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock to Streamline Capital Structure

Stock Information for TriSalus Life Sciences Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About TriSalus Life Sciences Inc.

TriSalus Life Sciences to Participate in the Canaccord Genuity 45th Annual Growth Conference
TriSalus Life Sciences to Host Second Quarter 2025 Financial Results Conference Call
TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock
TriSalus Life Sciences Announces the Launch of the TriNav FLX Infusion System
TriSalus Life Sciences Announces Chief Financial Officer Transition With Appointment of David B. Patience
TriSalus Life Sciences Reports First Quarter 2025 Results and Provides Updated 2025 Guidance
TriSalus Life Sciences to Host First Quarter 2025 Financial Results Conference Call
TriSalus Life Sciences Announces $22.0 Million Private Placement Preliminary Q1 2025 Unaudited Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.